Control of intestinal inflammation by regulatory T cells

Immunological Reviews

Volumn 182, Issue , 2001, Pages 190-200

  Singh, Baljit ^a   Read, Simon ^a   Asseman, Chrystelle ^a,c,d   Malmström, Vivianne ^a   Mottet, Christian ^a   Stephens, Leigh A ^a   Stepankova, Renata ^b   Tlaskalova, Helena ^b   Powrie, Fiona ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; AUTOIMMUNITY; COLITIS; ENTERITIS; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION; BACTERIA; COLITIS; DENDRITIC CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035180067     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1820115.x     Document Type: Review

References (83)

1. T cells in inflammatory bowel disease: Protective and pathogenic roles
2. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
3. + T cells induce or protect from chronic intestinal inflammation in C.B-17 SCID mice
4. + T cells
5. + T cells
6. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
7. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice
8. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells
9. + T cells
10. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype
11. Altered immune responses in interleukin 10 transgenic mice
12. + T cells are important for the balance between protective and pathogenic cell-mediated immunity
13. Interleukin-10-deficient mice develop chronic enterocolitis
14. + T cells
15. + T cells: A population oft cells with immune regulatory activities in vitro
16. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
17. + Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
18. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
19. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
20. + immunoregulatory T cells that control autoimmune diabetes
21. - subpopulations
22. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo
23. + cells regulate CD8 cell anergy in neonatal tolerant mice
24. + T cells: A common basis between tumor immunity and autoimmunity
25. + thymocytes and peripheral T cells have immune suppressive activity in vitro
26. + T cells: A highly differentiated and apoptosis-prone population
27. Regulatory CD4 T cells: Expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency
28. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
29. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
30. + T cells
31. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
32. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene
33. + regulatory cells that control intestinal inflammation
34. + T cells regulate the expansion of peripheral CD4 T cells through the producdon of IL-10
35. high T cells to SCID recipients
36. + T-cells in the regulation of inflammatory responses in the intestine
37. The influence of normal microbial flora on the development of chronic mucosal inflammation
38. Innate immunity: The virtues of a nonclonal system of recognition
39. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
40. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats
41. Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus
42. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and γ interferon-dependent mechanism
43. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
44. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
45. + regulatory T cells induced by an agonist self-peptide
46. The third function of the thymus
47. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development
48. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
49. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
50. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4
51. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
52. + T cells
53. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar
54. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells
55. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
56. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
57. Expression and function of OX40 ligand on human dendritic cells
58. CD4 T cell traffic control: In vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles
59. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence
60. Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
61. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - A molecule related to nerve growth factor receptor
62. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers
63. OX-40: Life beyond the effector T cell stage
64. + T cells by blocking the CD40-CD 154 interactions
65. Interleukin-10 and the interleukin-10 receptor
66. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys
67. Induction of tolerance by IL-10-treated dendritic cells
68. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
69. Abrogation of TGF-β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
70. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor-β II receptor
71. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression oft helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation
72. TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression
73. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
74. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
75. Control of immune pathology by regulatory T cells
76. Regulatory T cells in autoimmunity
77. Animal models of autoimmunity and their relevance to human diseases
78. The role of different subsets of T regulatory cells in controlling autoimmunity
79. + T-cell subset inhibits antigen-specific T-call responses and prevents colitis
80. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
81. + T cells that prevent diabetes onset in nonobese diabetic mice
82. - thymocytes
83. + T cells